Therapeutic targeting of Src kinase in myofibroblast differentiation and pulmonary fibrosis

Journal of Pharmacology and Experimental Therapeutics

Volumn 351, Issue 1, 2014, Pages 87-95

  Hu, Meng ^a   Che, Pulin ^b   Han, Xiaosi ^b   Cai, Guo Qiang ^a   Liu, Gang ^a   Antony, Veena ^a   Luckhardt, Tracy ^a   Siegal, Gene P ^b   Zhou, Yong ^a   Liu, Rui Ming ^a   Desai, Leena P ^a   O'Reilly, Philip J ^a   Thannickal, Victor J ^a   Ding, Qiang ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN GEL; FIBRONECTIN; PROTEIN TYROSINE KINASE; SARACATINIB; TRANSFORMING GROWTH FACTOR BETA1; 1,3 BENZODIOXOLE DERIVATIVE; ACTIN; ENZYME INHIBITOR; QUINAZOLINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; MOUSE MODEL; MYOFIBROBLAST; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MOUSE; PULMONARY FIBROSIS;

ACTINS; ANIMALS; BENZODIOXOLES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COLLAGEN; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOFIBROBLASTS; PULMONARY FIBROSIS; QUINAZOLINES; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907167516     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.216044     Document Type: Article

References (63)

1. Adamson IY and Bowden DH (1974) The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77:185-197.
2. Ahluwalia MS, de Groot J, Liu WM, and Gladson CL (2010) Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies. Cancer Lett 298:139-149.
3. Aleshin A and Finn RS (2010) SRC: a century of science brought to the clinic. Neoplasia 12:599-607.
4. Boggon TJ and Eck MJ (2004) Structure and regulation of Src family kinases. Oncogene 23:7918-7927.
5. Cai GQ, Chou CF, Hu M, Zheng A, Reichardt LF, Guan JL, Fang H, Luckhardt TR, Zhou Y, and Thannickal VJ, et al. (2012) Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of a-smooth muscle actin filaments during myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol 303: L692-L702.
6. Cai GQ, Zheng A, Tang Q, White ES, Chou CF, Gladson CL, Olman MA, and Ding Q (2010) Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp Cell Res 316:1600-1609.
7. Calalb MB, Polte TR, and Hanks SK (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15:954-963.
8. Cary LA, Chang JF, and Guan JL (1996) Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 109:1787-1794.
9. Chang YM, Bai L, Liu S, Yang JC, Kung HJ, and Evans CP (2008) Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 27:6365-6375.
10. Darby I, Skalli O, and Gabbiani G (1990) Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63: 21-29.
11. Ding Q, Cai GQ, Hu M, Yang Y, Zheng A, Tang Q, Gladson CL, Hayasaka H, Wu H, and You Z, et al. (2013) FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis. Am J Pathol 182:1572-1584.
12. Ding Q, Gladson CL, Wu H, Hayasaka H, and Olman MA (2008) Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem 283: 26839-26849.
13. Ding Q, Grammer JR, Nelson MA, Guan JL, Stewart JE, Jr, and Gladson CL (2005) p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J Biol Chem 280:6802-6815.
14. Ding Q, Luckhardt T, Hecker L, Zhou Y, Liu G, Antony VB, deAndrade J, and Thannickal VJ (2011) New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs 71:981-1001.
15. Ding Q, Stewart J, Jr, Olman MA, Klobe MR, and Gladson CL (2003) The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J Biol Chem 278: 39882-39891.
16. Ding Q, Stewart J, Jr, Prince CW, Chang PL, Trikha M, Han X, Grammer JR, and Gladson CL (2002) Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62:5336-5343.
17. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG, Smaili S, Periyasamy SM, Hariri IM, and Fedorova L, et al. (2007) Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49:215-224.
18. Ernst M, Inglese M, Scholz GM, Harder KW, Clay FJ, Bozinovski S, Waring P, Darwiche R, Kay T, and Sly P, et al. (2002) Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J Exp Med 196:589-604.
19. Gabbiani G, Ryan GB, and Majne G (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549-550.
20. Gressner AM and Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10:76-99.
21. Grove LM, Southern BD, Jin TH, White KE, Paruchuri S, Harel E, Wei Y, Rahaman SO, Gladson CL, and Ding Q, et al. (2014) Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts. J Biol Chem 289: 12791-12804.
22. Hagood JS and Olman MA (2007) Muscle fatigue: MK2 signaling and myofibroblast differentiation. Am J Respir Cell Mol Biol 37:503-506.
23. Hagood JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, and Alexander CB, et al. (2005) Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 167:365-379.
24. Hales AM, Schulz MW, Chamberlain CG, and McAvoy JW (1994) TGF-beta 1 induces lens cells to accumulate alpha-smooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res 13:885-890.
25. Hauck CR, Hsia DA, and Schlaepfer DD (2002) The focal adhesion kinase-a regulator of cell migration and invasion. IUBMB Life 53:115-119.
26. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, and Thannickal VJ (2014) Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 231:231ra47 DOI: 10.1126/scitranslmed.3008182.
27. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, and Chaponnier C (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-2741.
28. Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, and Chaponnier C (2003) Alphasmooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 14:2508-2519.
29. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, and Gabbiani G (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816.
30. Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, Cui Z, and Thannickal VJ (2004) Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-b1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279:1359-1367.
31. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, and Thannickal VJ (2007) Combinatorial activation of FAK and AKT by transforming growth factor-b1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19:761-771.
32. Izbicki G, Segel MJ, Christensen TG, Conner MW, and Breuer R (2002) Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 83:111-119.
33. Iwano M and Neilson EG (2004) Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13:279-284.
34. Kis K, Liu X, and Hagood JS (2011) Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 13:e27-e51.
35. Lagares D, Busnadiego O, García-Fernández RA, Kapoor M, Liu S, Carter DE, Abraham D, Shi-Wen X, Carreira P, and Fontaine BA, et al. (2012) Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum 64:1653-1664.
36. Laurie SA, Goss GD, Shepherd FA, Reaume MN, Nicholas G, Philip L, Wang L, Schwock J, Hirsh V, and Oza A, et al. (2014) A phase II trial of saracatinib, an inhibitor of src kinases, in previously-treated advanced non-small-cell lung cancer: the Princess Margaret Hospital phase II consortium. Clin Lung Cancer 15:52-57.
37. Ley B, Collard HR, and King TE, Jr (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431-440.
38. Li Y, Jiang D, Liang J, Meltzer EB, Gray A, Miura R, Wogensen L, Yamaguchi Y, and Noble PW (2011) Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 208:1459-1471.
39. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, and Giancotti FG (2001) EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 155:447-458.
40. Moore BB and Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L152-L160.
41. Morrow CJ, Ghattas M, Smith C, Bönisch H, Bryce RA, Hickinson DM, Green TP, and Dive C (2010) Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters. Cancer Res 70:5931-5941.
42. Mouratis MA and Aidinis V (2011) Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 17:355-361.
43. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, and Matthay MA, et al. (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328.
44. Muro AF, Moretti FA, Moore BB, Yan M, Atrasz RG, Wilke CA, Flaherty KR, Martinez FJ, Tsui JL, and Sheppard D, et al. (2008) An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 177:638-645.
45. Okutani D, Lodyga M, Han B, and Liu M (2006) Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 291: L129-L141.
46. Parsons JT, Martin KH, Slack JK, Taylor JM, and Weed SA (2000) Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606-5613.
47. Phan SH, Thrall RS, and Ward PA (1980) Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis. Am Rev Respir Dis 121:501-506.
48. Reiske HR, Zhao J, Han DC, Cooper LA, and Guan JL (2000) Analysis of FAKassociated signaling pathways in the regulation of cell cycle progression. FEBS Lett 486:275-280.
49. Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, and Raghu G, et al. (2011) Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365:1079-1087.
50. Romeo S, Eyden B, Prins FA, Briaire-de Bruijn IH, Taminiau AH, and Hogendoorn PC (2006) TGF-beta1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone. J Pathol 208:26-34.
51. Shan B, Hagood JS, Zhuo Y, Nguyen HT, MacEwen M, Morris GF, and Lasky JA (2010) Thy-1 attenuates TNF-alpha-activated gene expression in mouse embryonic fibroblasts via Src family kinase. PLoS ONE 5:e11662.
52. Siesser PM, Meenderink LM, Ryzhova L, Michael KE, Dumbauld DW, García AJ, Kaverina I, and Hanks SK (2008) A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly. Cell Motil Cytoskeleton 65:25-39.
53. Simmons WL, Rivera KE, Curiel DT, Williams WF, and Olman MA (1998) Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs. Am J Respir Cell Mol Biol 18:307-314.
54. Skhirtladze C, Distler O, Dees C, Akhmetshina A, Busch N, Venalis P, Zwerina J, Spriewald B, Pileckyte M, and Schett G, et al. (2008) Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Arthritis Rheum 58:1475-1484.
55. Snider GL, Celli BR, Goldstein RH, O'Brien JJ, and Lucey EC (1978) Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied. Am Rev Respir Dis 117:289-297.
56. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polosukhin V, Zhao LH, Sakamoto H, and Blackwell TS, et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31:395-404.
57. Tanjore H, Cheng DS, Degryse AL, Zoz DF, Abdolrasulnia R, Lawson WE, and Blackwell TS (2011) Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress. J Biol Chem 286: 30972-30980.
58. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, and Thomas PE (2003) Myofibroblast differentiation by transforming growth factor-b1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 278:12384-12389.
59. Tuan TL and Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24.
60. Vittal R, Horowitz JC, Moore BB, Zhang H, Martinez FJ, Toews GB, Standiford TJ, and Thannickal VJ (2005) Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol 166:367-375.
61. Vittal R, Zhang H, Han MK, Moore BB, Horowitz JC, and Thannickal VJ (2007) Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases. J Pharmacol Exp Ther 321:35-44.
62. White ES, Thannickal VJ, Carskadon SL, Dickie EG, Livant DL, Markwart S, Toews GB, and Arenberg DA (2003) Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 168:436-442.
63. Zhong Q, Zhou B, Ann DK, Minoo P, Liu Y, Banfalvi A, Krishnaveni MS, Dubourd M, Demaio L, and Willis BC, et al. (2011) Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am J Respir Cell Mol Biol 45:498-509.